Greenwich LifeSciences, Inc. (GLSI)
↓ Download CSVKey ratios (FY2025)
-5480.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$19.45M | -$17.64M | -$9.33M | -$8.04M | -$4.60M | -$1.86M | -$3.43M | — |
| Net Income | -$19.36M | -$17.41M | -$8.89M | -$7.83M | -$4.57M | -$1.86M | -$3.43M | — |
| EPS (Diluted) | $-1.43 | $-1.34 | $-0.69 | $-0.61 | $-0.35 | — | — | — |
| Total Assets | $6.18M | $4.09M | $6.99M | $13.48M | $27.22M | $28.68M | $26.7K | — |
| Total Liabilities | $5.82M | $3.19M | $294.4K | $262.9K | $385.2K | $1.05M | $1.38M | — |
| Shareholders' Equity | $353.2K | $908.6K | $6.70M | $13.21M | $26.83M | $27.63M | -$1.35M | -$10.12M |
| Cash & Equivalents | $6.18M | $4.09M | $6.99M | $13.47M | $27.20M | $28.66M | $6.8K | — |
| Operating Cash Flow | -$9.91M | -$7.27M | -$6.48M | -$6.20M | -$4.29M | -$1.15M | -$293.3K | — |
| Shares Outstanding | 14.30M | 13.15M | 12.85M | 12.85M | 13.15M | 12.70M | 8.46M | — |